Figure 1.
Cumulative incidence in children with distinct single first-appearing autoantibody positivity (IAA or GADA) for progression to distinct single second-appearing autoantibody positivity. A: The cumulative incidence of the second-appearing autoantibody by months since first-appearing IAA. B: The cumulative incidence of the second-appearing autoantibody by months since first-appearing GADA. The lines represent IAA (blue line), GADA (black line), IA-2A (red line), and ZnT8A (green line).